Social determinants of health in studies assessing toxicities associated with immune checkpoint inhibitor treatment: A systematic review

被引:0
|
作者
Georgopoulou, S. [1 ]
Jaganathan, P. P. [2 ]
Droney, J. M. [3 ]
Howell, P. [4 ]
Macklin-Doherty, A. [5 ]
Young, K. [6 ]
Cruickshank, S. [7 ]
机构
[1] Royal Marsden Hosp Chelsea, Appl Hlth Res, London, England
[2] Chelsea & Westminster Hosp NHS Trust, Palliat Med, London, England
[3] Royal Marsden Hosp Chelsea, Symptom Control & Palliat Care Dept, London, England
[4] Royal Marsden Sch, London, England
[5] ICR Inst Canc Res, Lymphoma, London, England
[6] Royal Marsden Hosp Chelsea, Renal Melanoma Dept, London, England
[7] Royal Marsden Hosp Inst Canc Res, Appl Hlth Res, Chelsea, England
关键词
D O I
10.1016/j.annonc.2024.08.1941
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1846P
引用
收藏
页码:S1089 / S1089
页数:1
相关论文
共 50 条
  • [31] Social determinants of health are associated with physical therapy use: a systematic review
    Braaten, Amanda Day
    Hanebuth, Cannon
    McPherson, Holt
    Smallwood, Dashae
    Kaplan, Samantha
    Basirico, David
    Clewley, Derek
    Rethorn, Zachary
    BRITISH JOURNAL OF SPORTS MEDICINE, 2021, 55 (22) : 1293 - +
  • [32] Onset of psoriasis with immune checkpoint inhibitor therapy: A systematic review
    Tarafdar, Nawar
    Sachdeva, Muskaan
    Savinova, Iryna
    Lytvyn, Yuliya
    Maliyar, Khalad
    Georgakopoulos, Jorge R.
    Mufti, Asfandyar
    Yeung, Jensen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (02) : 392 - 395
  • [33] Immune checkpoint inhibitor use and tuberculosis: a systematic review of the literature
    Zaemes, Jacob
    Kim, Chul
    EUROPEAN JOURNAL OF CANCER, 2020, 132 : 168 - 175
  • [34] Identification of the PROMs used to assess ICI toxicities and HRQoL in patients receiving immune checkpoint inhibitor treatment in cancer care and their suitability: A systematic review
    Georgopoulou, Sofia
    Droney, Joanne
    Jaganathan, Poorni Priya
    Howell, Paul
    Macklin-Doherty, Aislinn
    Young, Kate
    Cruickshank, Susanne
    CANCER TREATMENT REVIEWS, 2025, 135
  • [35] Vasculitis associated with immune checkpoint inhibitors—a systematic review
    Anisha Daxini
    Keri Cronin
    Antoine G. Sreih
    Clinical Rheumatology, 2018, 37 : 2579 - 2584
  • [36] Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review
    Kawakami, Naoki
    Saito, Hiroaki
    Takahashi, Susumu
    Kajie, Shinpei
    Kato, Rina
    Shimaya, Kazuhiro
    Wakai, Yoko
    Saito, Kazuhito
    Sakashita, Mai
    SEMINARS IN ONCOLOGY, 2022, 49 (06) : 439 - 455
  • [37] Reporting Quality in Health Economic Evaluation Studies of Immune Checkpoint Inhibitors: A Systematic Review
    Yoshioka, Takashi
    Azuma, Shintaro
    Funada, Satoshi
    Itaya, Takahiro
    Goto, Rei
    CLINICAL DRUG INVESTIGATION, 2025,
  • [38] TREATMENT OUTCOMES OF IMMUNE CHECKPOINT INHIBITOR (ICI) HEPATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Hwang, Soo Young
    Hsieh, Pinghsin
    Zhang, Wei
    GASTROENTEROLOGY, 2024, 166 (05) : S1696 - S1696
  • [39] Treatment of immune checkpoint inhibitoremediated psoriasis: A systematic review
    Said, Jordan Taylor
    Elman, Andrew
    Perez-Chada, Lourdes Maria
    Mita, Carol
    Merola, Joseph F.
    LeBoeuf, Nicole R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (02) : 399 - 400
  • [40] Immune checkpoint inhibitor–associated myocarditisCase reports and a review of the literature
    T. E. Osinga
    S. F. Oosting
    P. van der Meer
    R. A. de Boer
    B. C. Kuenen
    A. Rutgers
    L. Bergmann
    T. H. Oude Munnink
    M. Jalving
    M. van Kruchten
    Netherlands Heart Journal, 2022, 30 : 295 - 301